AMGEN INC (AMGN) Stock Price, Quote, News and Overview
NASDAQ:AMGN - Nasdaq - US0311621009 - Common Stock - Currency: USD
AMGN Quote, Performance and Key Statistics
AMGEN INC
NASDAQ:AMGN (2/5/2025, 10:38:08 AM)
304.855
+15.84 (+5.48%)
The current stock price of AMGN is 304.855 USD. In the past month the price increased by 10.64%. In the past year, price decreased by -0.72%.
AMGN Latest News, Press Releases and Analysis
Friday's pre-market session: top gainers and losers in the S&P500 index
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Amgen (AMGN) Q4 2024 Earnings Call Transcript
AMGN earnings call for the period ending December 31, 2024.
Amgen Surpasses Q4 Earnings Forecasts
Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.
Amgen’s (NASDAQ:AMGN) Q4 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 10.9% year on year to $9.09 billion. The company’s full-year revenue guidance of $35 billion at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $5.31 per share was 4.6% above analysts’ consensus estimates.
Amgen’s (NASDAQ:AMGN) Q4 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 10.9% year on year to $9.09 billion. The company’s full-year revenue guidance of $35 billion at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $5.31 per share was 4.6% above analysts’ consensus estimates.
AMGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.08 | 341.15B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 956.71 | 125.65B | ||
| GILD | GILEAD SCIENCES INC | 22.46 | 124.02B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.6 | 78.25B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.68B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.59B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.57B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.30B | ||
| NTRA | NATERA INC | N/A | 23.37B | ||
| BIIB | BIOGEN INC | 8.93 | 21.26B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.63 | 15.89B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.64B |
Related stock screener links
About AMGN
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 26,700 full-time employees. The firm discovers, develops, manufactures and delivers various human therapeutics. The company focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. The company operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Company Info
AMGEN INC
One Amgen Center Drive
Thousand Oaks CALIFORNIA 91320 US
CEO: Robert A. Bradway
Employees: 26700
Company Website: https://www.amgen.com/
Investor Relations: https://investors.amgen.com
Phone: 18054471000
AMGN FAQ
What is the stock price of AMGN?
The current stock price of AMGN is 304.855 USD.
What is the symbol for AMGEN INC stock?
The exchange symbol of AMGEN INC is AMGN and it is listed on the Nasdaq exchange.
On which exchange is AMGN stock listed?
AMGN stock is listed on the Nasdaq exchange.
Is AMGN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AMGN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AMGN.
Does AMGN stock pay dividends?
AMGN has a dividend yield of 3.3%. The yearly dividend amount is currently 8.52.
What is the Price/Earnings (PE) ratio of AMGN?
The PE ratio for AMGN is 15.38. This is based on the reported non-GAAP earnings per share of 19.82 and the current share price of 304.855 USD.
What is the Short Interest ratio of AMGN stock?
The outstanding short interest for AMGN is 2.13% of its float.
AMGN Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AMGN. When comparing the yearly performance of all stocks, AMGN is a bad performer in the overall market: 73% of all stocks are doing better.
AMGN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AMGN. While AMGN belongs to the best of the industry regarding profitability, there are concerns on its financial health.
AMGN Financial Highlights
Over the last trailing twelve months AMGN reported a non-GAAP Earnings per Share(EPS) of 19.82. The EPS increased by 6.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13% | ||
| ROA | 4.65% | ||
| ROE | 56.2% | ||
| Debt/Equity | 7.55 |
AMGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to AMGN. The Buy consensus is the average rating of analysts ratings from 39 analysts.
For the next year, analysts expect an EPS growth of 6.98% and a revenue growth 4.04% for AMGN